Hip replacement alternative has 96% implant survivorship, 10-year study finds

A decadelong FDA landmark study of a hip replacement alternative has been completed, NBC affiliate KPLC reported Jan. 3. 

Advertisement

The study examined the Birmingham Hip Resurfacing procedure, which takes a bone-conserving approach for patients. The procedure, which is ideal for male patients younger than 55, uses an implant that resembles a cap on a tooth, according to the report.

John Noble Jr., MD, of Center for Advanced Orthopaedics in Lake Charles, La., was a co-author of the study. He was one of the first surgeons in the U.S. to perform a Birmingham Hip Resurfacing case.

“I am pleased to report that the results of our 10-year study demonstrated that BHR has a 96 percent survivorship of the implant at 10 years post-procedure, with particularly successful results in younger, active male patients,” he told the station. “This procedure gives us an ideal solution for those patients with hip pain who would be considered too young and active for a traditional hip replacement.”

The results of the study were published in The Journal of Bone & Joint Surgery.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.